Dr. Tara O'Donohue, MD
Claim this profileMemorial Sloan Kettering Cancer Center
Area of expertise
Cancer
Tara O'Donohue, MD has run 10 trials for Cancer. Some of their research focus areas include:
Brain Tumor
Tara O'Donohue, MD has run 10 trials for Brain Tumor. Some of their research focus areas include:
Affiliated Hospitals
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
Clinical Trials Tara O'Donohue, MD is currently running
Repotrectinib
for Solid Tumors in Young Patients
Phase 1 will evaluate the safety and tolerability at different dose levels of repotrectinib in pediatric and young adult subjects with advanced or metastatic malignancies harboring anaplastic lymphoma kinase (ALK), receptor tyrosine kinase encoded by the gene ROS1 (ROS1), or neurotrophic receptor kinase genes encoding TRK kinase family (NTRK1-3) alterations to estimate the Maximum Tolerated Dose (MTD) or Maximum Administered Dose (MAD) and select the Pediatric Recommended Phase 2 Dose (RP2D). Phase 2 will determine the anti-tumor activity of repotrectinib in pediatric and young adult subjects with advanced or metastatic malignancies harboring ROS1 or NTRK1-3 alterations.
Recruiting
1 award
Phase 1 & 2
14 criteria
Repotrectinib + Chemotherapy
for Cancer
This trial tests the safety and effectiveness of repotrectinib combined with chemotherapy in children and young adults with severe, spreading cancer. The goal is to find the best dose with few side effects and see if it works well to stop cancer growth.
Recruiting
1 award
Phase 1 & 2
More about Tara O'Donohue, MD
Clinical Trial Related
8 years of experience running clinical trials · Led 13 trials as a Principal Investigator · 4 Active Clinical Trials
Treatments Tara O'Donohue, MD has experience with
- Repotrectinib
- Larotrectinib
- Selpercatinib
- Tipifarnib
- Irinotecan And Temozolomide
- Neratinib
Breakdown of trials Tara O'Donohue, MD has run
Cancer
Brain Tumor
Lymphoma
Solid Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Tara O'Donohue, MD specialize in?
Tara O'Donohue, MD focuses on Cancer and Brain Tumor. In particular, much of their work with Cancer has involved Stage I patients, or patients who are Stage II.
Is Tara O'Donohue, MD currently recruiting for clinical trials?
Yes, Tara O'Donohue, MD is currently recruiting for 4 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Tara O'Donohue, MD has studied deeply?
Yes, Tara O'Donohue, MD has studied treatments such as Repotrectinib, Larotrectinib, Selpercatinib.
What is the best way to schedule an appointment with Tara O'Donohue, MD?
Apply for one of the trials that Tara O'Donohue, MD is conducting.
What is the office address of Tara O'Donohue, MD?
The office of Tara O'Donohue, MD is located at: Memorial Sloan Kettering Cancer Center, New York, New York 10065 United States. This is the address for their practice at the Memorial Sloan Kettering Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.